Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy
Lokesh K. Kadian et al, 2024, Molecular and Cellular Biochemistry CrossRef
m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1
Jia Xu et al, 2024, Oncology Reports CrossRef
Alternative Splicing, Epigenetic Modifications and Cancer: A Dangerous Triangle, or a Hopeful One?
Francisco Gimeno-Valiente et al, 2022, Cancers CrossRef
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility
Yongqi Ding et al, 2023, Aging CrossRef
Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets
Ya Lu et al, 2022, Cell Death Discovery CrossRef
A review on the role of PCAT6 lncRNA in tumorigenesis
Soudeh Ghafouri-Fard et al, 2021, Biomedicine & Pharmacotherapy CrossRef
ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
Chaohua Zhang et al, 2023, Scientific Reports CrossRef
Integrated analysis using ToppMiR uncovers altered miRNA– mRNA regulatory networks in pediatric hepatocellular carcinoma—A pilot study
Senyo S. Whyte et al, 2023, Cancer Reports CrossRef
Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
Qiqi Chen et al, 2022, Disease Markers CrossRef
PCAT6 May Be a Whistler and Checkpoint Target for Precision Therapy in Human Cancers
Feng Jiang et al, 2021, Cancers CrossRef
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy
Mehrdad Hashemi et al, 2022, Pharmacological Research CrossRef
Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma
Lihong Yang et al, 2023, International Journal of Molecular Sciences CrossRef